Global and United States Hypertension Drug Market Report & Forecast 2022-2028

Global and United States Hypertension Drug Market Report & Forecast 2022-2028

Table of Contents
1 Study Coverage
1.1 Hypertension Drug Product Introduction
1.2 Global Hypertension Drug Outlook 2017 VS 2022 VS 2028
1.2.1 Global Hypertension Drug Sales in US$ Million for the Year 2017-2028
1.2.2 Global Hypertension Drug Sales in Volume for the Year 2017-2028
1.3 United States Hypertension Drug Outlook 2017 VS 2022 VS 2028
1.3.1 United States Hypertension Drug Sales in US$ Million for the Year 2017-2028
1.3.2 United States Hypertension Drug Sales in Volume for the Year 2017-2028
1.4 Hypertension Drug Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Hypertension Drug in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Hypertension Drug Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Hypertension Drug Market Dynamics
1.5.1 Hypertension Drug Industry Trends
1.5.2 Hypertension Drug Market Drivers
1.5.3 Hypertension Drug Market Challenges
1.5.4 Hypertension Drug Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Hypertension Drug Market Segment by Type
2.1.1 Calcium Channel Blockers
2.1.2 Diuretics
2.1.3 Beta Blockers Vasodilators
2.1.4 Angiotensin Converting Enzyme Inhibitors
2.1.5 Alpha Blockers
2.1.6 Angiotensin Receptor Blockers
2.1.7 Renin Inhibitors
2.2 Global Hypertension Drug Market Size by Type
2.2.1 Global Hypertension Drug Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Hypertension Drug Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Hypertension Drug Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Hypertension Drug Market Size by Type
2.3.1 United States Hypertension Drug Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Hypertension Drug Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Hypertension Drug Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Hypertension Drug Market Segment by Application
3.1.1 Hospital
3.1.2 Private Clinic
3.1.3 Others
3.2 Global Hypertension Drug Market Size by Application
3.2.1 Global Hypertension Drug Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Hypertension Drug Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Hypertension Drug Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Hypertension Drug Market Size by Application
3.3.1 United States Hypertension Drug Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Hypertension Drug Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Hypertension Drug Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Hypertension Drug Competitor Landscape by Company
4.1 Global Hypertension Drug Market Size by Company
4.1.1 Top Global Hypertension Drug Manufacturers Ranked by Revenue (2021)
4.1.2 Global Hypertension Drug Revenue by Manufacturer (2017-2022)
4.1.3 Global Hypertension Drug Sales by Manufacturer (2017-2022)
4.1.4 Global Hypertension Drug Price by Manufacturer (2017-2022)
4.2 Global Hypertension Drug Concentration Ratio (CR)
4.2.1 Hypertension Drug Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Hypertension Drug in 2021
4.2.3 Global Hypertension Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Hypertension Drug Manufacturing Base Distribution, Product Type
4.3.1 Global Hypertension Drug Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Hypertension Drug Product Type
4.3.3 Date of International Manufacturers Enter into Hypertension Drug Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Hypertension Drug Market Size by Company
4.5.1 Top Hypertension Drug Players in United States, Ranked by Revenue (2021)
4.5.2 United States Hypertension Drug Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Hypertension Drug Sales by Players (2020, 2021 & 2022)
5 Global Hypertension Drug Market Size by Region
5.1 Global Hypertension Drug Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Hypertension Drug Market Size in Volume by Region (2017-2028)
5.2.1 Global Hypertension Drug Sales in Volume by Region: 2017-2022
5.2.2 Global Hypertension Drug Sales in Volume Forecast by Region (2023-2028)
5.3 Global Hypertension Drug Market Size in Value by Region (2017-2028)
5.3.1 Global Hypertension Drug Sales in Value by Region: 2017-2022
5.3.2 Global Hypertension Drug Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Hypertension Drug Market Size YoY Growth 2017-2028
6.1.2 North America Hypertension Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Hypertension Drug Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Hypertension Drug Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Hypertension Drug Market Size YoY Growth 2017-2028
6.3.2 Europe Hypertension Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Hypertension Drug Market Size YoY Growth 2017-2028
6.4.2 Latin America Hypertension Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Hypertension Drug Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Hypertension Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Lupin Limited
7.1.1 Lupin Limited Corporation Information
7.1.2 Lupin Limited Description and Business Overview
7.1.3 Lupin Limited Hypertension Drug Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Lupin Limited Hypertension Drug Products Offered
7.1.5 Lupin Limited Recent Development
7.2 Novartis AG
7.2.1 Novartis AG Corporation Information
7.2.2 Novartis AG Description and Business Overview
7.2.3 Novartis AG Hypertension Drug Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Novartis AG Hypertension Drug Products Offered
7.2.5 Novartis AG Recent Development
7.3 Daiichi - Sankyo
7.3.1 Daiichi - Sankyo Corporation Information
7.3.2 Daiichi - Sankyo Description and Business Overview
7.3.3 Daiichi - Sankyo Hypertension Drug Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Daiichi - Sankyo Hypertension Drug Products Offered
7.3.5 Daiichi - Sankyo Recent Development
7.4 Pfizer Inc
7.4.1 Pfizer Inc Corporation Information
7.4.2 Pfizer Inc Description and Business Overview
7.4.3 Pfizer Inc Hypertension Drug Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Pfizer Inc Hypertension Drug Products Offered
7.4.5 Pfizer Inc Recent Development
7.5 Ranbaxy Laboratories Limited
7.5.1 Ranbaxy Laboratories Limited Corporation Information
7.5.2 Ranbaxy Laboratories Limited Description and Business Overview
7.5.3 Ranbaxy Laboratories Limited Hypertension Drug Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Ranbaxy Laboratories Limited Hypertension Drug Products Offered
7.5.5 Ranbaxy Laboratories Limited Recent Development
7.6 Sanofi S.A
7.6.1 Sanofi S.A Corporation Information
7.6.2 Sanofi S.A Description and Business Overview
7.6.3 Sanofi S.A Hypertension Drug Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Sanofi S.A Hypertension Drug Products Offered
7.6.5 Sanofi S.A Recent Development
7.7 AstraZeneca Plc
7.7.1 AstraZeneca Plc Corporation Information
7.7.2 AstraZeneca Plc Description and Business Overview
7.7.3 AstraZeneca Plc Hypertension Drug Sales, Revenue and Gross Margin (2017-2022)
7.7.4 AstraZeneca Plc Hypertension Drug Products Offered
7.7.5 AstraZeneca Plc Recent Development
7.8 Johnson & Johnson Ltd
7.8.1 Johnson & Johnson Ltd Corporation Information
7.8.2 Johnson & Johnson Ltd Description and Business Overview
7.8.3 Johnson & Johnson Ltd Hypertension Drug Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Johnson & Johnson Ltd Hypertension Drug Products Offered
7.8.5 Johnson & Johnson Ltd Recent Development
7.9 Boehringer Ingelheim
7.9.1 Boehringer Ingelheim Corporation Information
7.9.2 Boehringer Ingelheim Description and Business Overview
7.9.3 Boehringer Ingelheim Hypertension Drug Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Boehringer Ingelheim Hypertension Drug Products Offered
7.9.5 Boehringer Ingelheim Recent Development
7.10 Merck & Co.
7.10.1 Merck & Co. Corporation Information
7.10.2 Merck & Co. Description and Business Overview
7.10.3 Merck & Co. Hypertension Drug Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Merck & Co. Hypertension Drug Products Offered
7.10.5 Merck & Co. Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Hypertension Drug Industry Chain Analysis
8.2 Hypertension Drug Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Hypertension Drug Distributors
8.3 Hypertension Drug Production Mode & Process
8.4 Hypertension Drug Sales and Marketing
8.4.1 Hypertension Drug Sales Channels
8.4.2 Hypertension Drug Distributors
8.5 Hypertension Drug Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Hypertension Drug CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Hypertension Drug Market Trends
Table 3. Hypertension Drug Market Drivers
Table 4. Hypertension Drug Market Challenges
Table 5. Hypertension Drug Market Restraints
Table 6. Global Hypertension Drug Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Hypertension Drug Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Hypertension Drug Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Hypertension Drug Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Hypertension Drug Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Hypertension Drug Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Hypertension Drug Revenue Share by Manufacturer, 2017-2022
Table 13. Global Hypertension Drug Sales by Manufacturer, (K Units), 2017-2022
Table 14. Global Hypertension Drug Sales Share by Manufacturer, 2017-2022
Table 15. Global Hypertension Drug Price by Manufacturer (2017-2022) & (USD/Unit)
Table 16. Global Hypertension Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Hypertension Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hypertension Drug as of 2021)
Table 18. Top Players of Hypertension Drug in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Hypertension Drug Product Type
Table 20. Date of International Manufacturers Enter into Hypertension Drug Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Hypertension Drug Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Hypertension Drug Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Hypertension Drug Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Hypertension Drug Sales by Players, (K Units), 2020, 2021 & 2022
Table 26. United States Hypertension Drug Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Hypertension Drug Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Hypertension Drug Sales in Volume by Region (2017-2022) & (K Units)
Table 29. Global Hypertension Drug Sales in Volume Forecast by Region (2023-2028) & (K Units)
Table 30. Global Hypertension Drug Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Hypertension Drug Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Hypertension Drug Sales in Volume by Country (2017-2028) & (K Units)
Table 33. North America Hypertension Drug Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Hypertension Drug Sales in Volume by Region (2017-2028) & (K Units)
Table 35. Asia Pacific Hypertension Drug Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Hypertension Drug Sales in Volume by Country (2017-2028) & (K Units)
Table 37. Europe Hypertension Drug Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Hypertension Drug Sales in Volume by Country (2017-2028) & (K Units)
Table 39. Latin Americaa Hypertension Drug Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Hypertension Drug Sales in Volume by Country (2017-2028) & (K Units)
Table 41. Middle East and Africa Hypertension Drug Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Lupin Limited Corporation Information
Table 43. Lupin Limited Description and Business Overview
Table 44. Lupin Limited Hypertension Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 45. Lupin Limited Hypertension Drug Product
Table 46. Lupin Limited Recent Development
Table 47. Novartis AG Corporation Information
Table 48. Novartis AG Description and Business Overview
Table 49. Novartis AG Hypertension Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 50. Novartis AG Product
Table 51. Novartis AG Recent Development
Table 52. Daiichi - Sankyo Corporation Information
Table 53. Daiichi - Sankyo Description and Business Overview
Table 54. Daiichi - Sankyo Hypertension Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 55. Daiichi - Sankyo Product
Table 56. Daiichi - Sankyo Recent Development
Table 57. Pfizer Inc Corporation Information
Table 58. Pfizer Inc Description and Business Overview
Table 59. Pfizer Inc Hypertension Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 60. Pfizer Inc Product
Table 61. Pfizer Inc Recent Development
Table 62. Ranbaxy Laboratories Limited Corporation Information
Table 63. Ranbaxy Laboratories Limited Description and Business Overview
Table 64. Ranbaxy Laboratories Limited Hypertension Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Ranbaxy Laboratories Limited Product
Table 66. Ranbaxy Laboratories Limited Recent Development
Table 67. Sanofi S.A Corporation Information
Table 68. Sanofi S.A Description and Business Overview
Table 69. Sanofi S.A Hypertension Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 70. Sanofi S.A Product
Table 71. Sanofi S.A Recent Development
Table 72. AstraZeneca Plc Corporation Information
Table 73. AstraZeneca Plc Description and Business Overview
Table 74. AstraZeneca Plc Hypertension Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 75. AstraZeneca Plc Product
Table 76. AstraZeneca Plc Recent Development
Table 77. Johnson & Johnson Ltd Corporation Information
Table 78. Johnson & Johnson Ltd Description and Business Overview
Table 79. Johnson & Johnson Ltd Hypertension Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 80. Johnson & Johnson Ltd Product
Table 81. Johnson & Johnson Ltd Recent Development
Table 82. Boehringer Ingelheim Corporation Information
Table 83. Boehringer Ingelheim Description and Business Overview
Table 84. Boehringer Ingelheim Hypertension Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 85. Boehringer Ingelheim Product
Table 86. Boehringer Ingelheim Recent Development
Table 87. Merck & Co. Corporation Information
Table 88. Merck & Co. Description and Business Overview
Table 89. Merck & Co. Hypertension Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 90. Merck & Co. Product
Table 91. Merck & Co. Recent Development
Table 92. Key Raw Materials Lists
Table 93. Raw Materials Key Suppliers Lists
Table 94. Hypertension Drug Customers List
Table 95. Hypertension Drug Distributors List
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Hypertension Drug Product Picture
Figure 2. Global Hypertension Drug Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Hypertension Drug Market Size 2017-2028 (US$ Million)
Figure 4. Global Hypertension Drug Sales 2017-2028 (K Units)
Figure 5. United States Hypertension Drug Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Hypertension Drug Market Size 2017-2028 (US$ Million)
Figure 7. United States Hypertension Drug Sales 2017-2028 (K Units)
Figure 8. United States Hypertension Drug Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Hypertension Drug Market Share in Global, in Volume (K Units) 2017-2028
Figure 10. Hypertension Drug Report Years Considered
Figure 11. Product Picture of Calcium Channel Blockers
Figure 12. Product Picture of Diuretics
Figure 13. Product Picture of Beta Blockers Vasodilators
Figure 14. Product Picture of Angiotensin Converting Enzyme Inhibitors
Figure 15. Product Picture of Alpha Blockers
Figure 16. Product Picture of Angiotensin Receptor Blockers
Figure 17. Product Picture of Renin Inhibitors
Figure 18. Global Hypertension Drug Market Share by Type in 2022 & 2028
Figure 19. Global Hypertension Drug Sales in Value by Type (2017-2028) & (US$ Million)
Figure 20. Global Hypertension Drug Sales Market Share in Value by Type (2017-2028)
Figure 21. Global Hypertension Drug Sales by Type (2017-2028) & (K Units)
Figure 22. Global Hypertension Drug Sales Market Share in Volume by Type (2017-2028)
Figure 23. Global Hypertension Drug Price by Type (2017-2028) & (USD/Unit)
Figure 24. United States Hypertension Drug Market Share by Type in 2022 & 2028
Figure 25. United States Hypertension Drug Sales in Value by Type (2017-2028) & (US$ Million)
Figure 26. United States Hypertension Drug Sales Market Share in Value by Type (2017-2028)
Figure 27. United States Hypertension Drug Sales by Type (2017-2028) & (K Units)
Figure 28. United States Hypertension Drug Sales Market Share in Volume by Type (2017-2028)
Figure 29. United States Hypertension Drug Price by Type (2017-2028) & (USD/Unit)
Figure 30. Product Picture of Hospital
Figure 31. Product Picture of Private Clinic
Figure 32. Product Picture of Others
Figure 33. Global Hypertension Drug Market Share by Application in 2022 & 2028
Figure 34. Global Hypertension Drug Sales in Value by Application (2017-2028) & (US$ Million)
Figure 35. Global Hypertension Drug Sales Market Share in Value by Application (2017-2028)
Figure 36. Global Hypertension Drug Sales by Application (2017-2028) & (K Units)
Figure 37. Global Hypertension Drug Sales Market Share in Volume by Application (2017-2028)
Figure 38. Global Hypertension Drug Price by Application (2017-2028) & (USD/Unit)
Figure 39. United States Hypertension Drug Market Share by Application in 2022 & 2028
Figure 40. United States Hypertension Drug Sales in Value by Application (2017-2028) & (US$ Million)
Figure 41. United States Hypertension Drug Sales Market Share in Value by Application (2017-2028)
Figure 42. United States Hypertension Drug Sales by Application (2017-2028) & (K Units)
Figure 43. United States Hypertension Drug Sales Market Share in Volume by Application (2017-2028)
Figure 44. United States Hypertension Drug Price by Application (2017-2028) & (USD/Unit)
Figure 45. North America Hypertension Drug Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 46. North America Hypertension Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 47. U.S. Hypertension Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. Canada Hypertension Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. Europe Hypertension Drug Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 50. Europe Hypertension Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 51. Germany Hypertension Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. France Hypertension Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. U.K. Hypertension Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. Italy Hypertension Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. Russia Hypertension Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. Asia-Pacific Hypertension Drug Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 57. Asia-Pacific Hypertension Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 58. China Hypertension Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Japan Hypertension Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. South Korea Hypertension Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. India Hypertension Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Australia Hypertension Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Taiwan Hypertension Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Indonesia Hypertension Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Thailand Hypertension Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Malaysia Hypertension Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Philippines Hypertension Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Latin America Hypertension Drug Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 69. Latin America Hypertension Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 70. Mexico Hypertension Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. Brazil Hypertension Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Argentina Hypertension Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Middle East & Africa Hypertension Drug Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 74. Middle East & Africa Hypertension Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 75. Turkey Hypertension Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 76. Saudi Arabia Hypertension Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 77. U.A.E Hypertension Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 78. Hypertension Drug Value Chain
Figure 79. Hypertension Drug Production Process
Figure 80. Channels of Distribution
Figure 81. Distributors Profiles
Figure 82. Bottom-up and Top-down Approaches for This Report
Figure 83. Data Triangulation
Figure 84. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Pulmonary Arterial Hypertension (Pah) Medicine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Pulmonary Arterial Hypertension (Pah) Medicine market: According to our latest research, the global Pulmonary Arterial Hypertension (Pah) Medicine market looks promising in the next 5 years. As of 2022, the global Pulmonary Arterial Hypertension (Pah) Medicine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to ......

Global Nifedipine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 102

Market Overview of Global Nifedipine market: According to our latest research, the global Nifedipine market looks promising in the next 5 years. As of 2022, the global Nifedipine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Nifedipine market, with a systematical de......

Global Amlodipine Besylate Market Research Report 2024

Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 115

The Amlodipine Besylate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amlodipine Besylate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profil......

Pulmonary Arterial Hypertension (PAH) Drugs - Global Market Insights and Sales Trends 2024

Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 112

The global Pulmonary Arterial Hypertension (PAH) Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pulmonary Arterial Hypertension (PAH) Drugs in various end use industries. The expanding demands from the Hospitals, Clinics and Other,, are propelling Pulmonary Arterial Hypertension (PAH) Drugs market. Inhalation, one of the segments analysed in this report, is projected to record % ......

Captopril API - Global Market Insights and Sales Trends 2024

Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 100

The global Captopril API market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Captopril API in various end use industries. The expanding demands from the Captopril Tablet, Compound Captopril Tablet and Captopril Injection,, are propelling Captopril API market. 98% Captopril API, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the......

Telmisartan - Global Market Insights and Sales Trends 2024

Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 107

The global Telmisartan market size is expected to reach US$ 3631.3 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Telmisartan in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Telmisartan market. Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Freeze-Dried......

Global Ambrisentan Professional Survey Report 2023, Forecast to 2028

Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 106

Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......

Global Ambrisentan Market Research Report 2023, Forecast to 2028

Published: 20-Dec-2023        Price: US 2680 Onwards        Pages: 132

Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......

Global Amlodipine Besylate Professional Survey Report 2023, Forecast to 2028

Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 133

Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs